How do we assess whether the QT interval is abnormal: Myths, formulae and fixed opinion

Clinical Toxicology

Volumn 53, Issue 4, 2015, Pages 189-191

  Isbister, Geoffrey K ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; AUSTRALIAN; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DIGITALIS INTOXICATION; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; EMERGENCY PHYSICIAN; HEART ARRHYTHMIA; HUMAN; LITERATURE; NOTE; PHYSICIAN; PROSPECTIVE STUDY; QT INTERVAL; QT PROLONGATION; RESUSCITATION; RISK ASSESSMENT; TACHYCARDIA; TORSADE DES POINTES; UNITED STATES; CHEMICALLY INDUCED; DRUG OVERDOSE; FEMALE; LONG QT SYNDROME; MALE; STATISTICS AND NUMERICAL DATA;

DRUG OVERDOSE; FEMALE; HUMANS; LONG QT SYNDROME; MALE; PRACTICE PATTERNS, PHYSICIANS';

EID: 84961291554     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2015.1014044     Document Type: Note

References (18)

1. Othong R, Devlin JP, Kazzi Z. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States, Europe and Asia Pacifi c region. Clin Toxicol 2015; 53:xx.
2. Chan AS, Isbister GK, Kirkpatrick CM, Duffull SB. Assessing risk of a prolonged QT interval-a survey of emergency physicians. Int J Emerg Med 2008; 1:35-41.
3. Isbister G K, Page C B. Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice. Br J Clin Pharmacol 2013; 76:48-57.
4. Isbister G K. Risk assessment of drug-induced QT prolongation. Australian Prescriber 2015; 38:20-24.
5. Malik M, Camm AJ. Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling. Drug Saf 2001; 24:323-351.
6. Berling I, Isbister GK, Calver L, Clunas S. Digital Holter measurement of QT prolongation in ziprasidone overdose. Clin Toxicol (Phila) 2011; 49:694-696.
7. Isbister GK, Calver L, van Gorp F, Stokes B, Page CB. Inter-rater reliability of manual QT measurement and prediction of abnormal QT, HR pairs. ClinToxicol (Phila) 2009; 47:884-888.
8. Malik M, Camm AJ. Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling. Drug Saf 2001; 24:323-351.
9. Hunt AC. Accuracy of popular automatic QT interval algorithms assessed by a 'gold standard' and comparison with a Novel method: computer simulation study. BMC Cardiovasc Disord 2005; 5:29.
10. Batchvarov V, Malik M. Individual patterns of QT/RR relationship. Card Electrophysiol Rev 2002; 6:282-288.
11. Friberg LE, Isbister GK, Duffull SB. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol 2006; 61:177-190.
12. Piotrovsky V. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation. AAPS J 2005; 7:E609-E24.
13. Chan A, Isbister GK, Kirkpatrick CM, Dufful SB. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 2007; 100:609-615.
14. Isbister G K, Balit C R, Macleod D, Duffull S B. A misulpride overdose is frequently associated with QT prolongation and torsades de pointes. J Clin Psychopharmacol 2010; 30:391-395.
15. Isbister GK, Duffull SB. Quetiapine overdose: predicting intubation, duration of ventilation, cardiac monitoring and the effect of activated charcoal. Int Clin Psychopharmacol 2009; 24:174-180.
16. van Gorp F, Whyte I M, Isbister G K. Clinical and ECG effects of escitalopram overdose. Ann Emerg Med 2009; 54:404-408.
17. Waring WS, Graham A, Gray J, Wilson AD, Howell C, Bateman DN. Evaluation of a QT nomogram for risk assessment after antidepressant overdose. Br J Clin Pharmacol 2010; 70:881-885.
18. Berling I, Isbister GK. Prolonged QT risk assessment in antipsychotic overdose using the QT nomogram. Ann Emerg Med 2015; 65:pii: S0196-0644(14)01573-X. doi: 10.1016/j.annemergmed.2014.12.005.